Sotorasib (Lumakras)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sotorasib (Lumakras), covering 2025-08-15 to 2025-08-15. Get the full timeline:
Most recent: Clinical Trial Update: 5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Patients Non-eligible for a Doublet/Triplet Chemotherapy With Advanced Unresectab [Phase 2]